This Article contains typographical errors.
In the Results section under subheading 'In vivo anticancer activity against Ehrlich ascites Carcinoma (EAC)' "The experimental results showed that 3-AWA reduced Ehrlich ascites carcinoma by 71.75% at 10 mg/kg intraperitoneal dose in comparison to the tumor growth inhibition of 87.4% in 5-FU (22 mg/kg i.p.) treated group. " should read:
"The experimental results showed that 3-AWA reduced Ehrlich ascites carcinoma by 70.5% at 10 mg/kg intraperitoneal dose in comparison to the tumor growth inhibition of 87.4% in 5-FU (22 mg/kg i.p.) treated group. "
In the legend of Table 1 "Values are mean ± S.E. (n = 7, 10 for control). " 
